Protocol

Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)

Protective-antigen classification feature comparison · Table 1.. Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Sources

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1.: Val Accuracy, Protective-antigen classification feature comparison

3 evaluations · 21 metric rows

At a glance

Inputs, training, access and other details

Explanatory profile: limited source coverage · Automated source review, 2026-09-17. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.

Data, procedure and scoring
Property	Description and evidence
Datasets	Not extracted or verified for this record.
Organisms	Not extracted or verified for this record.
Assays	Not extracted or verified for this record.
Splits	Not extracted or verified for this record.
Allowed inputs	Not extracted or verified for this record.
Adaptation	Not extracted or verified for this record.
Metrics	Not extracted or verified for this record.
Baselines	Not extracted or verified for this record.

How it works

Evaluation in this paper

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Sources

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1.: Val Accuracy, Protective-antigen classification feature comparison

Evaluation design

Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.

Tasks

vaccine-antigen candidate prediction

These source-backed links do not make different protocols or scores interchangeable.

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Published comparisons

Explore the results reported under one evaluation protocol. Each figure keeps its source, dataset and metric together; it is not a ranking across studies.

Comparison and metric

Protective-antigen classification feature comparison · Table 1.

Val Accuracy (fraction) · Higher values are better for this metric.

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Evaluation protocol · Protective-antigen classification feature comparison

Original · Configuration · Author-reported evaluation0.96 ± 0.008
ESM Only · Configuration · Author-reported evaluation0.96 ± 0.005
Combined · Configuration · Author-reported evaluation0.97 ± 0.004

Source order is preserved. Plotted marks show point estimates; uncertainty, where reported, is retained in the printed values and table. Differences do not establish statistical significance.

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1.: Val Accuracy, Protective-antigen classification feature comparison

Values, uncertainty and evidence

Val Accuracy: original source values
Tested entity	Printed value	Uncertainty	Evidence
Original · Configuration	0.96 ± 0.008 fraction	type: reported_plus_minus_type_unresolved; value: 0.008	Author-reported evaluation · source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2
ESM Only · Configuration	0.96 ± 0.005 fraction	type: reported_plus_minus_type_unresolved; value: 0.005	Author-reported evaluation · source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Val Accuracy; XML row3 column2
Combined · Configuration	0.97 ± 0.004 fraction	type: reported_plus_minus_type_unresolved; value: 0.004	Author-reported evaluation · source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2

Scope and limitations

Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.
Published prose states specificity equal but table contains differences; table values retained.
No interval assigned unless printed in source cell.

Source transcription and grouping reviewed by automated source review on 2026-09-17. These experiments were not independently reproduced by rewire.

Tested entities and results

Release 2026-09-17-d277315f7d76 · 3 evaluations · 21 metric rows. Different protocols are not a single leaderboard.

Evaluation setupMetricEvidence origin

Results grouped by the exact reported evaluation
Metric and finding	Coverage and uncertainty	Evidence
ESM Only: Protective-antigen classification feature comparison Configuration: ESM OnlyProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)Dataset: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Author-reported evaluation · Evaluation metadata: needs review
0.85 ± 0.036 AUPRC Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.036 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUPRC; XML row3 column7 Source checking is not independent reproduction.
0.98 ± 0.004 Specificity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.004 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Specificity; XML row3 column4 Source checking is not independent reproduction.
0.75 ± 0.063 Sensitivity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.063 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Sensitivity; XML row3 column3 Source checking is not independent reproduction.
0.96 ± 0.005 Val Accuracy Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.005 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Val Accuracy; XML row3 column2 Source checking is not independent reproduction.
0.77 ± 0.043 MCC Unit: dimensionless · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.043 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column MCC; XML row3 column6 Source checking is not independent reproduction.
0.94 AUROC Unit: fraction · Direction: higher	Uncertainty: unreported Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUROC; XML row3 column8 Source checking is not independent reproduction.
0.96 ± 0.007 Weighted F1 Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.007 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Weighted F1; XML row3 column5 Source checking is not independent reproduction.
Combined: Protective-antigen classification feature comparison Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)Dataset: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Author-reported evaluation · Evaluation metadata: needs review
0.85 ± 0.021 MCC Unit: dimensionless · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.021 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column MCC; XML row4 column6 Source checking is not independent reproduction.
0.99 ± 0.004 Specificity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.004 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Specificity; XML row4 column4 Source checking is not independent reproduction.
0.97 ± 0.004 Weighted F1 Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.004 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Weighted F1; XML row4 column5 Source checking is not independent reproduction.
0.97 ± 0.004 Val Accuracy Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.004 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2 Source checking is not independent reproduction.
0.92 ± 0.013 AUPRC Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.013 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUPRC; XML row4 column7 Source checking is not independent reproduction.
0.83 ± 0.045 Sensitivity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.045 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Sensitivity; XML row4 column3 Source checking is not independent reproduction.
0.97 AUROC Unit: fraction · Direction: higher	Uncertainty: unreported Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUROC; XML row4 column8 Source checking is not independent reproduction.
Original: Protective-antigen classification feature comparison Configuration: OriginalProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)Dataset: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Author-reported evaluation · Evaluation metadata: needs review
0.94 AUROC Unit: fraction · Direction: higher	Uncertainty: unreported Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUROC; XML row2 column8 Source checking is not independent reproduction.
0.96 ± 0.008 Weighted F1 Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.008 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Weighted F1; XML row2 column5 Source checking is not independent reproduction.
0.78 ± 0.046 MCC Unit: dimensionless · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.046 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column MCC; XML row2 column6 Source checking is not independent reproduction.
0.84 ± 0.049 AUPRC Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.049 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUPRC; XML row2 column7 Source checking is not independent reproduction.
0.74 ± 0.071 Sensitivity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.071 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Sensitivity; XML row2 column3 Source checking is not independent reproduction.
0.96 ± 0.008 Val Accuracy Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.008 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2 Source checking is not independent reproduction.
0.99 ± 0.004 Specificity Unit: fraction · Direction: higher	Uncertainty: type: reported plus minus type unresolved; value: 0.004 Scored: Not reported · Eligible: Not reported	source checkedEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Specificity; XML row2 column4 Source checking is not independent reproduction.

Papers and result coverage

Last literature check: 2026-09-17. Primary-source discovery and table/protocol screening; source checked is not independently reproduced. Raw acquisitions not automatically numerical publication approval.

Paper or primary resource	Version	Reference
Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features	preprint version in PMC	Read source DOI: 10.1101/2024.09.04.611295

What is still missing

Independent batch review before import; preserve existing observation identities.

Search and extraction details

complete comparison tables extracted pending publication review

Searches

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features primary paper benchmark results

Evidence locations

Table 1.: Val Accuracy, Protective-antigen classification feature comparison

Strengths and limitations

Strengths and considerations

No source-reviewed explanatory claims are recorded here yet.

Limitations and conditions

No source-reviewed explanatory claims are recorded here yet.

Profile review details

Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.

Stable record: paper-protocol-a7bf3c8f6b432c3093

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

3 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-09-17-d277315f7d76
Property and statement	Original source and location	Review and provenance
Evaluation in this paper Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Individual claims	Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Original source ↗ Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC Retrieved: 2026-09-17T07:56:15.123850+00:00	source checked automated source review · 2026-09-17 Audit details Primary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: `attributes.profile.sections.0.body` Source artifact SHA-256: `b76fff917addd0e9ff8a2fc843496132ecf832d3ceef248e3edf2dbc78baab5f` Hash scope: Exact retrieved primary paper artifact bytes. Inspected artifact
Introduction Protective-antigen classification feature comparison · Table 1.. Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Individual claims	Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Original source ↗ Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC Retrieved: 2026-09-17T07:56:15.123850+00:00	source checked automated source review · 2026-09-17 Audit details Primary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: `attributes.profile.summary` Source artifact SHA-256: `b76fff917addd0e9ff8a2fc843496132ecf832d3ceef248e3edf2dbc78baab5f` Hash scope: Exact retrieved primary paper artifact bytes. Inspected artifact
Relationship: evaluates task reported-task-47465954d606e6 Individual claims	Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Original source ↗ Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC Retrieved: 2026-09-17T07:56:15.123850+00:00	source checked automated source review · 2026-09-17 Audit details Field: `links:evaluates_task:reported-task-47465954d606e6` Claim: paper-claim-6875cf87327d9dc4af Source artifact SHA-256: `b76fff917addd0e9ff8a2fc843496132ecf832d3ceef248e3edf2dbc78baab5f` Hash scope: Exact retrieved primary paper artifact bytes. Inspected artifact

All evidence (CSV)All evidence (JSONL)How to read the evidence

Sources and history

Release 2026-09-17-d277315f7d76 · Record review: needs review

1 source records and release history

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Original source · preprint version in PMC

Download this release

Technical metadata and extraction receipts

Stable ID: paper-protocol-a7bf3c8f6b432c3093

areas: proteins-complexes
tasks: vaccine-antigen candidate prediction
entity level: protocol
protocol: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.
comparison panels: id: part2-vaxign-esm-2024-T1-1dcdb2e905; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: Val Accuracy; unit: fraction; direction: higher; result ids: paper-result-cff4683107e593c8b4; paper-result-6884d284eba92a5c06; paper-result-7af576f4ade426848e; source ids: part2-vaxign-esm-2024; source locator: Table 1.: Val Accuracy, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-aaa5cd1083; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: Sensitivity; unit: fraction; direction: higher; result ids: paper-result-c8bfac2d90d81feeb3; paper-result-5b5f63e259d93937fa; paper-result-e97d7b6a6ecb22428f; source ids: part2-vaxign-esm-2024; source locator: Table 1.: Sensitivity, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-a4c286072e; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: Specificity; unit: fraction; direction: higher; result ids: paper-result-ef311f3bd240402622; paper-result-368137517fff441366; paper-result-4fbe5feb8bf19db3cf; source ids: part2-vaxign-esm-2024; source locator: Table 1.: Specificity, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-7185c1558b; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: Weighted F1; unit: fraction; direction: higher; result ids: paper-result-651ddc5c811de9e8bb; paper-result-f4fc84c79d3f4a5dd2; paper-result-6314ca1ea38e3cc0b5; source ids: part2-vaxign-esm-2024; source locator: Table 1.: Weighted F1, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-e43ff059cc; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: MCC; unit: dimensionless; direction: higher; result ids: paper-result-774bc1695cb59c05ac; paper-result-bc30cb500a5d4c0a21; paper-result-0588c3eaf97f2abf9e; source ids: part2-vaxign-esm-2024; source locator: Table 1.: MCC, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-6ed0c48e92; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: AUPRC; unit: fraction; direction: higher; result ids: paper-result-7b567777b97aa43653; paper-result-04617e3534e8f83c6d; paper-result-b0ccdc4a3d8bbe1ae7; source ids: part2-vaxign-esm-2024; source locator: Table 1.: AUPRC, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17; id: part2-vaxign-esm-2024-T1-0189da3e2b; title: Protective-antigen classification feature comparison · Table 1.; protocol id: paper-protocol-a7bf3c8f6b432c3093; dataset id: paper-dataset-c1edd1f6f7e93d9f6e; metric: AUROC; unit: fraction; direction: higher; result ids: paper-result-11bf48c7b68484cc04; paper-result-d002da139f31ba9e3f; paper-result-ff4ba6f92feb183bff; source ids: part2-vaxign-esm-2024; source locator: Table 1.: AUROC, Protective-antigen classification feature comparison; context: Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.; caveats: Reported± values preserved; uncertainty type and resampling denominator not established in inspected methods.; Published prose states specificity equal but table contains differences; table values retained.; No interval assigned unless printed in source cell.; review: method: automated_source_review; date: 2026-09-17
benchmark research: review date: 2026-09-17; status: complete_comparison_tables_extracted_pending_publication_review; primary sources: part2-vaxign-esm-2024; inspected locators: Table 1.: Val Accuracy, Protective-antigen classification feature comparison; searched queries: Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features primary paper benchmark results; gaps: Independent batch review before import; preserve existing observation identities.; claim scope: Primary-source discovery and table/protocol screening; source checked is not independently reproduced. Raw acquisitions not automatically numerical publication approval.
legacy kinds: benchmark
entity classification: review date: 2026-09-17; rationale: The source-backed record identifies a specified evaluated procedure and its dataset/split/scoring context. Classify it as a protocol while preserving version and comparison restrictions.; source ids: part2-vaxign-esm-2024; source locator: Table 1.: Val Accuracy, Protective-antigen classification feature comparison; ambiguities: None recorded

Related records

Suggest a correction